Development of an in Vitro 3D Tumor Model to Study Therapeutic Efficiency of an Anticancer Drug

被引:105
|
作者
Shin, Crystal S. [1 ]
Kwak, Bongseop [2 ]
Han, Bumsoo [2 ,3 ]
Park, Kinam [1 ,3 ]
机构
[1] Purdue Univ, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
[2] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA
[3] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA
关键词
3D tumor model; multicellular tumor spheroids; hydrogel; microfluidic channel; drug delivery systems; BREAST-CANCER; MULTICELLULAR SPHEROIDS; CELL-CULTURE; GLUTARALDEHYDE; FABRICATION; GELATIN;
D O I
10.1021/mp300595a
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The importance and advantages of three-dimensional (3D) cell cultures have been well-recognized. Tumor cells cultured in a 3D culture system as multicellular tumor spheroids (MTS) can bridge the gap between in vitro and in vivo anticancer drug evaluations. An in vitro 3D tumor model capable of providing close predictions of in vivo drug efficacy will enhance our understanding, design, and development of better drug delivery systems Here, we developed an in vitro 3D tumor model by adapting the hydrogel template strategy to culture uniformly sized spheroids in a hydrogel scaffold containing microwells. The in vitro 3D tumor model was to closely simulate an in vivo solid tumor and its microenvironment for evaluation of anticancer drug delivery systems. MTS cultured in the hydrogel scaffold are used to examine the effect of culture conditions on the drug responses Free NITS released from the scaffold are transferred to a microfluidic channel to simulate a dynamic in vivo rnicroenvironment. The in vitro 3D tumor model that mimics biologically relevant parameters of in vivo microenvironments such as cell-cell and cell-ECM interactions, and a dynamic environment would be a valuable device to examine efficiency of anticancer drug and targeting specificity. These models have potential to provide in vivo correlated information to improve and optimize drug delivery systems for an effective chemotherapy.
引用
收藏
页码:2167 / 2175
页数:9
相关论文
共 50 条
  • [1] 3D tumor model - a platform for anticancer drug development
    Kazmierski, Lukasz
    Maj, Malgorzata
    PHYSICAL SCIENCES REVIEWS, 2021, : 1835 - 1860
  • [2] Development of in vitro 3D multicellular cancer model for anticancer drug screening.
    Kim, S.
    Oh, S.
    Bae, I.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [3] An in vitro osteosarcoma 3D microtissue model for drug development
    Rimann, Markus
    Laternser, Sandra
    Gvozdenovic, Ana
    Muff, Roman
    Fuchs, Bruno
    Kelm, Jens M.
    Graf-Hausner, Ursula
    JOURNAL OF BIOTECHNOLOGY, 2014, 189 : 129 - 135
  • [4] Establishing an In Vitro 3D Spheroid Model to Study Medulloblastoma Drug Response and Tumor Dissemination
    Roper, Sophie J.
    Coyle, Beth
    CURRENT PROTOCOLS, 2022, 2 (01):
  • [5] Development of a 3D in vitro model of the prostate tumor microenvironment.
    Iyer, Divya
    Bonteanu, Andrei
    Zhu, Jedidiah Z.
    Shepherd, Peter
    Kittles, Rick
    Navone, Nora M.
    Harrington, Daniel A.
    Dexter, Dwayne
    Bircsak, Kristin M.
    CANCER RESEARCH, 2021, 81 (13)
  • [6] A Non-Mulberry Silk Fibroin Protein Based 3D In Vitro Tumor Model for Evaluation of Anticancer Drug Activity
    Talukdar, Sarmistha
    Kundu, Subhas C.
    ADVANCED FUNCTIONAL MATERIALS, 2012, 22 (22) : 4778 - 4788
  • [7] Co-culture of 3D tumor spheroids with fibroblasts as an in vitro model for drug resistance study
    Kim, Sun-Ah
    Kuh, Hyo-Jeong
    CANCER RESEARCH, 2014, 74 (19)
  • [8] 3D bioprinting of an in vitro hepatoma microenvironment model: Establishment, evaluation, and anticancer drug testing
    Wang, Xiaoyuan
    Yang, Xiaoning
    Liu, Zixian
    Shen, Zhizhong
    Li, Meng
    Cheng, Rong
    Zhao, Liting
    Xi, Yanfeng
    Wang, Jianming
    Sang, Shengbo
    ACTA BIOMATERIALIA, 2024, 185 : 173 - 189
  • [9] The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy
    Wu, Shidi
    Huisman, Bertine W.
    Rietveld, Marion H.
    Rissmann, Robert
    Vermeer, Maarten H.
    Van Poelgeest, Mariette I. E.
    El Ghalbzouri, Abdoelwaheb
    CELLULAR ONCOLOGY, 2024, 47 (03) : 883 - 896
  • [10] 3-D tumor model for in vitro evaluation of anticancer drugs
    Horning, Jayme L.
    Sahoo, Sanjeeb K.
    Vijayaraghavalu, Sivakumar
    Dimitrijevic, Sanja
    Vasir, Jaspreet K.
    Jain, Tapan K.
    Panda, Amulya K.
    Labhasetwar, Vinod
    MOLECULAR PHARMACEUTICS, 2008, 5 (05) : 849 - 862